Given the observed dysregulation of SNHG14 in CRC, its involvement in tumor–stroma immune interactions via extracellular vesicles and/or exosomes is suggested, which underscores its relevance in immunity, inflammation, and tumor–stroma immune interplay. The gene discussed is SNHG14; the disease is neoplasm.